Oxysterol-binding protein-related protein 8 (ORP8) increases sensitivity of hepatocellular carcinoma cells to Fas-mediated apoptosis

Journal of Biological Chemistry

Volumn 290, Issue 14, 2015, Pages 8876-8887

  Zhong, Wenbin ^a   Qin, Shengying ^a   Zhu, Biying ^a   Pu, Miaoshui ^b   Liu, Fupei ^a   Wang, Lin ^a   Ye, Guilin ^a   Yi, Qing ^c   Yan, Daoguang ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; CELL MEMBRANES; CYTOLOGY; PROTEINS; T-CELLS; TISSUE; TUMORS;

CELL PLASMA MEMBRANES; CELL SENSITIVITY; ENDOPLASMIC RETICULUM STRESS RESPONSE; HEALTHY SUBJECTS; HEPATOCELLULAR CARCINOMA CELL; HUMAN HEPATOMA CELLS; OXYSTEROL-BINDING-PROTEIN-RELATED PROTEINS; POTENTIAL TARGETS;

CELLS;

FAS ANTIGEN; FAS LIGAND; LENTIVIRUS VECTOR; LIPID BINDING PROTEIN; MICRORNA 143; OXYSTEROL BINDING PROTEIN RELATED PROTEIN 8; POLYETHYLENEIMINE; PROTEIN P53; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; OXYSTEROL BINDING PROTEIN; PRIMER DNA; STEROID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE OVEREXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; TUMOR XENOGRAFT; UPREGULATION; FLOW CYTOMETRY; LIVER TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, STEROID;

EID: 84926629847     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.610188     Document Type: Article

References (33)

1. Pinkoski, M. J., Brunner, T., Green, D. R., and Lin, T. (2000) Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278, G354-G366
2. Schulze-Bergkamen, H., and Krammer, P. H. (2004) Apoptosis in cancer: implications for therapy. Semin. Oncol. 31, 90-119
3. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243
4. Galle, P. R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., and Runkel, L. (1995) Involvement of the CD95(APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230
5. Faubion, W. A., and Gores, G. J. (1999) Death receptors in liver biology and pathobiology. Hepatology 29, 1-4
6. Wang, X., Lu, Y., and Cederbaum, A. I. (2005) Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. Hepatology 42, 400-410
7. Ogawa, K., Yasumura, S., Atarashi, Y., Minemura, M., Miyazaki, T., Iwamoto, M., Higuchi, K., and Watanabe, A. (2004) Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. J. Hepatol. 40, 278-284
8. Natoli, G., Ianni, A., Costanzo, A., De Petrillo, G., Ilari, I., Chirillo, P., Balsano, C., and Levrero, M. (1995) Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11, 1157-1164
9. Ito, Y., Monden, M., Takeda, T., Eguchi, H., Umeshita, K., Nagano, H., Nakamori, S., Dono, K., Sakon, M., Nakamura, M., Tsujimoto, M., Nakahara, M., Nakao, K., Yokosaki, Y., and Matsuura, N. (2000) The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma. Brit. J. Cancer 82, 1211-1217
10. Higaki, K., Yano, H., and Kojiro, M. (1996) Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and non-cancerous tissues. Am. J. pathol. 149, 429-437
11. Yan, D., Mäyränpää, M. I., Wong, J., Perttilä, J., Lehto, M., Jauhiainen, M., Kovanen, P. T., Ehnholm, C., Brown, A. J., and Olkkonen, V. M. (2008) OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J. Biol. Chem. 283, 332-340
12. Zhou, T., Li, S., Zhong, W., Vihervaara, T., Béaslas, O., Perttilä, J., Luo, W., Jiang, Y., Lehto, M., Olkkonen, V. M., and Yan, D. (2011) OSBP-related protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with the nucleoporin Nup62. PLoS ONE 6, e21078
13. Béaslas, O., Vihervaara, T., Li, J., Laurila, P. P., Yan, D., and Olkkonen, V. M. (2012) Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacity. Exp. Cell Res. 318, 1933-1945
14. Zhong, W., Zhou, Y., Li, J., Mysore, R., Luo, W., Li, S., Chang, M. S., Olkkonen, V. M., and Yan, D. (2014) OSBP-related protein 8 (ORP8) interacts with Homo sapiens sperm-associated antigen 5 (SPAG5) and mediates oxysterol interference of HepG2 cell cycle. Exp. Cell Res. 322, 227-235
15. Jordan, S. D., Krüger, M., Willmes, D. M., Redemann, N., Wunderlich, F. T., Brönneke, H. S., Merkwirth, C., Kashkar, H., Olkkonen, V. M., Böttger, T., Braun, T., Seibler, J., and Brüning, J. C. (2011) Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 13, 434-446
16. Dessì, S., Batetta, B., Pulisci, D., Spano, O., Anchisi, C., Tessitore, L., Costelli, P., Baccino, F. M., Aroasio, E., and Pani, P. (1994) Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73, 253-258
17. Zhang, X., Liu, S., Hu, T., Liu, S., He, Y., and Sun, S. (2009) Up-regulated microRNA-143 transcribed by nuclear factor κB enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50, 490-499
18. Yano, H., Fukuda, K., Haramaki, M., Momosaki, S., Ogasawara, S., Higaki, K., and Kojiro, M. (1996) Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines. J. Hepatol. 25, 454-464
19. Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., and Galle, P. R. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nat. Med. 2, 1361-1366
20. Bennett, M., Macdonald, K., Chan, S. W., Luzio, J. P., Simari, R., and Weissberg, P. (1998) Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282, 290-293
21. el-Khatib, M., Stanger, B. Z., Dogan, H., Cui, H., and Ju, S. T. (1995) The molecular mechanism of FasL-mediated cytotoxicity by CD4+ Th1 clones. Cell. Immunol. 163, 237-244
22. Lowin, B., Mattman, C., Hahne, M., and Tschopp, J. (1996) Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int. Immunol. 8, 57-63
23. Pahl, H. L., and Baeuerle, P. A. (1997) The ER-overload response: activation of NF-κB. Trends Biochem. Sci. 22, 63-67
24. Pahl, H. L., and Baeuerle, P. A. (1995) A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-κB. EMBO J. 14, 2580-2588
25. Hsu, S. C., Gavrilin, M. A., Lee, H. H., Wu, C. C., Han, S. H., and Lai, M. Z. (1999) NF-κB-dependent Fas ligand expression. Eur. J. Immunol. 29, 2948-2956
26. Kim, I., Xu, W., and Reed, J. C. (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug. Discov. 7, 1013-1030
27. Du, X., Kumar, J., Ferguson, C., Schulz, T. A., Ong, Y. S., Hong, W., Prinz, W. A., Parton, R. G., Brown, A. J., and Yang, H. (2011) A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking. J. Cell Biol. 192, 121-135
28. Jiang, H. Y., Wek, S. A., McGrath, B. C., Scheuner, D., Kaufman, R. J., Cavener, D. R., and Wek, R. C. (2003) Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-κB in response to diverse cellular stresses. Mol. Cell Biol. 23, 5651-5663
29. Deng, J., Lu, P. D., Zhang, Y., Scheuner, D., Kaufman, R. J., Sonenberg, N., Harding, H. P., and Ron, D. (2004) Translational repression mediates activation of nuclear factor κB by phosphorylated translation initiation factor 2. Mol. Cell Biol. 24, 10161-10168
30. Wang, X., and Cederbaum, A. I. (2007) Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and -independent pathways. Free Radic. Biol. Med. 42, 971-984
31. Sassen, S., Miska, E. A., and Caldas, C. (2008) MicroRNA: implications for cancer. Virchows Arch. 452, 1-10
32. Zhao, X., Yang, Z., Li, G., Li, D., Zhao, Y., Wu, Y., Robson, S. C., He, L., Xu, Y., Miao, R., and Zhao, H. (2012) The role and clinical implications of microRNAs in hepatocellular carcinoma. Science China 55, 906-919
33. Trakooljul, N., Hicks, J. A., and Liu, H. C. (2010) Identification of target genes and pathways associated with chicken microRNA miR-143. Anim. Genet. 41, 357-364